Dr. Yizhou Dong named 2018 Young Innovator in Cellular and Molecular Bioengineering

September 7, 2018

Young Innovator group picture
News Story Content
Text

The Ohio State University College of Pharmacy associate professor Yizhou Dong, PhD was recently named a Biomedical Engineering Society (BMES) 2018 Young Innovator in Cellular and Molecular Bioengineering and his work will be featured in the October 2018 issue of the BMES journal. Dr. Dong will also present his research at the 2018 Fall BMES Conference in Atlanta, Georgia.

In his work to be featured in the journal, Dr. Dong and co-authors incorporated a series of biogradable and biocompatible polymer materials into the formulation of tricarboxamide derived lipid-like nanomaterial (TT3-LLN) to develop lipid polymer hybrid nanoparticles (LPNs). The team then evaluated the mRNA delivery efficiency of different LPNs, and a systematic orthogonal optimization was carried out. Through their research, the team found new insights that could potentially assist develop LPNs and mRNA based therapeutics.

Since arriving at Ohio State in 2014, Dr. Dong has filed over a dozen invention disclosures and has ten provisional patents pending. Dr. Dong was recently recognized by Columbus Business First in the 201 7 class of “40 under 40”. Critically, Dr. Dong’s technologies have garnered commercial interest to translate his findings into improved patient outcomes.

BMES Young Innovators are selected from active members of BMES and the competition is open to tenure track faculty who are working in the field of cellular and molecular bioengineering.